Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-14,400
Closed -$681K 3901
2018
Q4
$681K Buy
14,400
+200
+1% +$12K ﹤0.01% 2911
2018
Q3
$1.06M Buy
+14,200
New +$978K ﹤0.01% 2668

Other funds holding SRDX

David Shaw's SRDX Position: Q4 2025 in Review

David Shaw sold out of Surmodics (SRDX) in Q4 2025, closing a stake of 74,422 shares — an estimated $2.22M sold.

David Shaw first reported a position in SRDX in Q3 2013 and held it in 45 quarters. The position peaked at $4.99M in Q4 2024. 1 fund tracked by Wall St. Rank holds SRDX as of Q4 2025.

  • David Shaw reported no remaining Surmodics position as of Q4 2025 after selling out during the quarter.
  • David Shaw sold 74,422 Surmodics shares in Q4 2025, an estimated $2.22M.
  • David Shaw first reported a position in Surmodics in Q3 2013 and held it in 45 quarters.
  • David Shaw's Surmodics position peaked at $4.99M in Q4 2024.
  • 1 fund tracked by Wall St. Rank held Surmodics as of Q4 2025.

Based on D.E. Shaw & Co's 13F filing for Q4 2025, filed 17 Feb 2026.